GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for putative nicotine oxidoreductase (B1N1A3)

Analyse AlphaFold monomer V2.0 prediction for putative nicotine oxidoreductase (B1N1A3) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B1N1A3
Type
protein
Length
618 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xc0F878C3f3E2a1874e2A6daC80d429e553DdB0D5
Molecule
Putative nicotine oxidoreductase
UniProt
B1N1A3
Pockets
10 · best druggability 0.62

Structure

1 distinct chain · 45% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APutative nicotine oxidoreductaseprotein61845% helix, 16% strandB1N1A3

Pockets

10 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13400.620.7851empty
22090.570.7928empty
3530.460.8510empty
41700.420.7321empty
51240.400.7525empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.